MEDROXYPROGESTERONE acetate, 150mg, 1ml, vial

STD DINJMEDR1V-

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
G03AC06
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

MEDROXYPROGESTERONE 150mg

Full Name

Synonym: depot medroxyprogesterone acetate (DMPA) or Depo-Provera®

Therapeutic Action

Long-acting synthetic progestogen

Indications

Long-acting female contraception (3 months)

Long-term treatment of functional uterine bleeding

Instructions for use

Must be given as deep IM injection every 3 months.

Shake the vial well before administration to make the injectable suspension homogeneous.

    Precautions for Use

    Contraindicated during pregnancy.

    Storage

    • Below 25ºC
    • Do not refrigerate. Do not freeze.